Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ziprasidone in the Treatment of Borderline Personality Disorder

This study has been completed.
Ministry of Health, Spain
REM-TAP Network
Information provided by:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Identifier:
First received: March 11, 2008
Last updated: NA
Last verified: March 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2006
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):